International ME/CFS Conference 2026

Scientific Conference centred on the latest findings from research on disease mechanisms and insights from clinical trials investigating treatments for ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) and post-COVID syndrome. The two-day hybrid event on 7 and 8 May 2026 is directed at medical professionals, researchers and interdisciplinary experts in the fields of medicine and biology.


The event takes place as an online livestream broadcast from the Harnack House of the Max Planck Society in Berlin, Germany. Presentations will be held in English. Day two of the Conference features an afternoon Symposium for a German speaking audience (for further information on the agenda and speakers, see below).

The organisers have called for the submission of abstracts for scientific posters (deadline 1 March), which will be exhibited on-site (and online) on May 7-8 May.

Registration for online participation is now open (link to registration below).

Under the stewardship of Prof Carmen Scheibenbogen, Director of the Division of Immunodeficiencies and Post-infectious Diseases and the Charité Fatigue Center (CFC) at Charité – Universitätsmedizin Berlin, Germany, the Conference will bring together leading international experts to present the latest research on ME/CFS.

Contributions will be centred on the latest findings from research on disease mechanisms; ranging from insights into genetics, biomarkers, and imaging, to vascular, neuronal, immune and metabolic dysfunction. Day two of the Conference will be entirely centred on showcasing recent data and results from clinical trials investigating treatments, with a focus on interventions targeting immune dysregulation. Additionally, there will be a Symposium summarising ongoing research in Germany.

Contributions will be centred on ME/CFS, while also highlighting research on Long COVID and post-COVID syndrome.

Videos, presentations and short summaries of the lectures will be made publicly available after the event.